CD33 Antibody, anti-human, VioBlue®, REAfinity™ 130-111-024 from Miltenyi Biotec | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
Miltenyi Biotec for
CD33 Antibody, anti-human, VioBlue®, REAfinity™

Miltenyi Biotec's CD33 Antibody, anti-human, VioBlue®, REAfinity™ is a Human monoclonal antibody. The CD33 Antibody, anti-human, VioBlue®, REAfinity™ was generated using CD33 as the antigen. It reacts with Homo Sapiens, and Human. This antibody has been shown to work in applications such as: Mass Cytometry, and Flow Cytometry.

Product Specs
ItemCD33 Antibody, anti-human, VioBlue®, REAfinity™
CompanyMiltenyi Biotec
Price $350.00Supplier Page View Company Product Page
Catalog Number130-111-024
Quantity100 tests in 200 µL
ApplicationsFlow cytometry, Mass cytometry
Conjugate/TagVioBlue
Reactivityhuman
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
Concentration1:50
IsotypeREA Control Antibody (S), human IgG1
CloneREA775
Hosthuman cell line
ModificationsRecombinantly engineered
TargetCD33
Regulatory StatusFor research use only
TypeAntibodies
Source/Expression Systemhuman cell line
Clonalitymonoclonal
NCBI Full Gene NameCD33 molecule
NCBI Gene AliasesSIGLEC-3, SIGLEC3, p67
Research AreaFor research use only

Add to Compare List

Miltenyi Biotec

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

(1) Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological MalignanciesFrontiers in immunologyJanuary 1, 2022Soldierer M, Bister A, Haist C, Thivakaran A, Cengiz SC, Sendker S, Bartels N, Thomitzek A, Smorra D, Hejazi M, et al.

(2) A study of CD33 (SIGLEC-3) antigen expression and function on activated human T and NK cells: two isoforms of CD33 are generated by alternative splicingJournal of leukocyte biologyJanuary 1, 2006Hernández-Caselles T, Martínez-Esparza M, Pérez-Oliva AB, Quintanilla-Cecconi AM, García-Alonso A, Alvarez-López DM, García-Peñarrubia P.

(3) Isolation of a cDNA encoding CD33, a differentiation antigen of myeloid progenitor cellsJournal of immunology (Baltimore, Md. : 1950)October 15, 1988Simmons D, Seed B.

(4) Treatment of acute myeloid leukemia cells in vitro with a monoclonal antibody recognizing a myeloid differentiation antigen allows normal progenitor cells to be expressedThe Journal of clinical investigationApril 1, 1987Bernstein ID, Singer JW, Andrews RG, Keating A, Powell JS, Bjornson BH, Cuttner J, Najfeld V, Reaman G, Raskind W.

Be the First to Write a Review!